text:
We want … Information, about the Village
I spent a fair chunk of time at the recent game convention trying to find a group about to start the Village. I failed (although I wasn't trying that hard). But I discovered that two locals had recently acquired a copy and so last night they were both there and I tried a game.
It's not exactly a worker placement. Perhaps a 'limited action selection' is better. Your workers don't block, but each space has a set number of actions that can be taken each turn. But workers often sit in an area and score points at the end of the game for advancement.
Of course, the twist is that actions spend time. After so much time one of your (oldest) workers must die. Given that the game ends when all the good graves (that score points) or bad ones (that don't) fill, I was hoping for a clever cut throat game of time management. I suppose I got it, a bit.
The Village is clever, but it's an intricate cube processing game, nothing more. Time is just one more resource to manage. With a zillion options I decided on the relatively simple "Build resources up early, spend them for points starting at the halfway point." I had a few other handy-dandy rules.
- Pick the best action (hewing to 'resources early, points late') and don't think too much long term.
- I don't have that color? I should probably get some. Pick colors I don't have when selecting an action.
- Quickly rush to get a few younger workers, so that I could advance them slowly. Early on I tossed a few elders at the monastary (since they'd get actionless points each turn) and crafting (so I could get cheaper resources). The town hall would have probably been fine, too, since you can get two free cubes or a free tile (once you get to the 3rd spot). But there are more crafting actions each turn.
- Get a plot relatively fast. And horse/ox. (Again, resource efficiency).
- Once the midgame hit, start travelling (with an elder) and hit the market hard.
- It seems to me that everyone will have to have 3 dead people by the end, and 4 is average, so rushing to get your 5th person in the (good) ground is a pretty decent swing. Really the most interesting decision is how to do that and make sure you don't have an extra death you can't afford (although you'll get 7 extra points for a good death, so a bad death that later costs you six isn't horrible).
Anyway, it's fine, but the decisions seemed straightforward. Is the time mechanism enough to keep me from calling it a JASE? I'm not sure. Probably.
Rating –Indifferent Plus, until I decide.
8 Responses
There are a number of interesting aspects about Village, but its most distinguishing feature is Death Management. With experienced players, there's often a race to get Granny to croak and grab that last scoring grave. Of course, you need to make sure you still have enough members of the younger generation to be able to carry out actions. I view it as a WP game, since that implies a LIMITED number of spots for each action, not necessarily only one. The fact that action selection also gives you a cube is another innovative aspect.
It's not a classical cube processor, since in most cases the conversion isn't a direct one, but for all intents and purposes it fits that description. I like it, but I suspect it's a game far more suited for my tastes than for yours.
Well, apart from the action contention (which it does have) a worker placement game feels constrained by your number of workers (or some other cost per action, like the $$ per placement in Caylus). Agricola, for example, has a brutal race to get your 3rd worker. So it's not just "one worker per space."
Here there are simply X actions per player divided up (ignoring the well). Sometimes you need an available worker to take an action (traveller/monk) or to get a discount (craftsman convert time to goods instead of cubes), but it's a pretty mild constraint.
You said that when collecting cubes you tended to choose colors you don't have when selecting actions. I don't think that's necessarily best – I would think choosing colors to support your strategy (Green for Council/Market, Pink/Orange for traveling, Brown for heavy-hitting the Church…), and beyond that I think it might be wise to collect the SAME colors in order to make 3 of a kind so you can use the Well.
I haven't played the game in a while, and I'm no expert, but that is the comment that struck me as potentially naive. Spreading the colors out sounds like it lacks focus, and what I remember noticing in this game is that you don't do well if you try to do everything, you have to sort of concentrate on 2 or 3 scoring methods (out of the 5 in the game). Then again, maybe there are enough uses for any given color to support concentrating on 2-3 scoring avenues, in which case your plan could work well!
I agree with Seth. A good thing about The Village is, that it allows to focus on a strategy, where you can actually ignore a building (or two), while in most Euros you have to do everything sooner or later. So spreading colours is not necessary the best option.
(A single reply to Seth/Peer)
I could have phrased it better. In general the color selection is (early on) secondary to the action selection (with the obvious 'don't take black without a reason' exception). But I think the basic idea applies.
If you are using lots of green (for example), you will tend to be short of green. So you'll grab it.
Taking a single action over and over doesn't earm extra points (you only get the VP for a spot you end the game in, not when you advance. As the rules were explained to me, anyway). To get to 6VP in the civic building requires four advancements over the course of the game.
The one exception is just pounding money to VP over and over, which also requires getting money as well as advancing City Hall. Travelling does give you VP, but none of these actions really seem that much more efficient than mixing them up. (I doubt someone who pounds $$ via city hall and ignores travelling will do better that someone who does some travelling and advances to the 6VP slot of city hall, but never converts.
And, as always, points earned later are worth just as much as points earned early. So flexibility early on seems advised.
Of course none of this applies to the endgame, when I map out my needs much more directly (and often one of those needs will be the well, which does encourage sets of three). But I think that (like Puerto Rico) "focusing on a strategy" means "optimization that isn't as flexible as the early game"
Early/midgame having cube diversity can be quite useful, as it lets you be flexible in deciding on your path (depending on other people's actions/cubes that come up). You can almost always find a use for a cube, particularly since several of the paths require cube diversity and let you get other cubes.
I think the game is cool because of the death mechanism. Without it, it would be just another cube pusher, but managing the deaths makes it fun.
There is also a bit of 'do a strategy that others arent focusing on', which is also nice. If a strategy dominates, then multiple players compete by focusing on it and it gets weaker.
The time mechanism is weird because death is both a cost and a benefit.


text:
Register | Garage | Photo Gallery | FAQ | Calendar | Search | Today's Posts | Mark Forums Read | Auto Escrow | Insurance |
C900 Performance, Mods & Tuning Covers Tuning & Performance modifications for the Classic 900 (C900) |
Thread Tools | Display Modes |
T5 non-turbo/TURBO LPG???
OK I want to know if it is worth putting T5 on two cars that we have.
My 1993 T16 Lucas and my dads a 1990 non turbo Iv'e read up the T5 thread at the top and a few other on the web, and I am just trying to get my head around it and if it will do what I want. I'm interested in the 1995 ng900 as a donour as I read that it is much more simpler than the 9000 loom. We want to run the cars as dual fuel (predominantly LPG) as LPG is still half the cost here in australia. 1. does it need to be a turbo loom? 2. Is there any advantage having T5 on my 900 turbo? or will I loose all the advantages when I go with LPG? 3. same as question 2, but on the 1990 900i? thanks everyone |
Sponsored Links | ||
| ||
I assume you are going to "fog it" or use an LP carb (mixer) ahead of the throttle plate and not try and inject the LP with LP injectors, no? I think you will loose everything when you run the LP system. You'll need to shut down the gas system as it is not good to fire the injectors dry all day. On the turbo that would mean the LP would be introduced ahead of the turbo.
I know over here, on the propane powered delivery trucks they use a modified system that allows for propane to be injected into the manifold in place of the gasoline system, but they are not duel fuel. Never done a conversion on a electroinc fuel injected engine so not sure how they do it. If the timeing portion is "stand alone" (independant of the fuel injection part of the system) then I can see it working. If it is all tied in (and I think it is) then you'll have problems. I think the best thing is to find a fleet of trucks set up for duel fuel and talk to the mechainic that maintaines them, they will have a good idea of the problems assocated with duel fuel on a modern electronic engine. |
Quite a few problems will be caused by the ion-sensing in the spark plugs for the engine position sensing... I'm guessing.
For the 900i the main benefit would have been saving fuel from the sequential injector firing. But if you are using LPG then you won't be using standard injectors so the fuel-saving won't be there. On the flip side, of course you are going to save money by using the cheaper fuel so that won't matter. I'm pretty sure you can get solenoid LPG injectors. Would have to get high-impedence injectors to avoid compatibility issues with the T5. The ECU would have to have a serious bit of mapping done to get the best out of the LPG. That's assuming the LPG does not mess too much with the ion-sensing. |
| |
He said he wanted dual fuel which just about limits the LP funtion to a mixer ahead of the throttle plate. I know of no injectors that can be used for both fuels. Any way you look at it, I don't think it will be simple nor idealized for either fuel. Which is why most LP powered trucks now made are for vapor fuel only (LP/NG) and not gasoline also.
true, but I am open to dedicated LPG, what I want to know would T5 work to control gas injectors? as I have been told that it is not a feasable option with the c900 cpu etc. As of now the only option I have with the car is dual fuel, with as you said a mixer ahead of the throttle body but after the turbo, going for a lpg tank where the petrol tank is usually fitted, and fitting a 22litre petrol tank just infront of the rear axel (there is room) have tank made!! Maybe I should be asking in the ng900 forum if they have had experience with vapor lpg injection using the T5? and replacing the injectors? If there is a kit for the ng900 and I had T5 would there be any reason this would not work? Obviously there would be a bit of customising. |
Mixer systems work on a the demand/flow of the air thru the mixer being below atmospheic pressure. If you tried to place after the turbo it would shut off the flow. There might be someway to modifie the regualator so it "senses" the manifold pressure but that would be even more complicated, and require a regulator that can take being pressureized in places where they aren't normally. I have done several LP and duel fuel conversions but only on "carb'd" engines. All in all, I think if I wanted LP on my Saab. I would have to think long and hard before picking up a wrench or buying anything. |
I took the car in to a lpg convertor fitter, who does LPG conversions on high powered turbo V8's he had just finished a 400hp holden, now I migh havesaid it wrong, he said he would put a mixer infront of the throttle body, I'm certain it was vapour, as it was a new kind of setup not the old spud kind. and yes I am thinking long and hard been looking and reaing for 2 years now |
Sponsored Links | |
| |
Bookmarks |
Tags |
lpg, lucas |
Thread Tools | |
Display Modes | |
Similar Threads | ||||
Thread | Thread Starter | Forum | Replies | Last Post |
1999 9-5 4cyl turbo, replaced vacuum lines, now turbo doesnt work | ghallgrimson | 9-5 Workshop | 1 | 14th October 2011 09:07 PM |
For Sale: Turbo from a 1999 9-3 SE High Output (SOLD: 3" Down Pipe, but not the turbo) | steviethev | Parts for Sale/Wanted - North America | 9 | 7th June 2011 05:58 PM |
1989 Saab 900 Turbo- Using Turbo at Hi RPM's Blow My bRake Ligth Fuse | petersenpak | C900 Performance, Mods & Tuning | 4 | 8th April 2010 09:51 AM |
1989 Saab 900 Turbo Convertable- Brake Light Fuse+Turbo | petersenpak | C900 Workshop | 0 | 6th April 2010 10:51 PM |
O Turbo, Turbo, wherefore art thou Turbo? | dazw101 | NG900 & OG9-3 Workshop | 9 | 18th July 2008 03:05 PM |

subset: commoncrawl


text:
Using Windows Live Movie Maker software to create and edit movies gives you access to a range of editing tools, processing features and visual effects. To edit a video, image or audio object in Movie Maker, you'll first need to highlight the object in the program's movie storyboard and timeline pane. Once it's highlighted and selected, edit or transform the object with the tools available in Movie Maker's menu ribbon.
Launch Windows Live Movie Maker. Click "File" in the main menu and then select "New Project" from the pull-down menu to start a new Movie Maker project.
Click the "Home" tab in the main menu ribbon. In the "Add" group, click the "Add Videos and Photos" button. Navigate to the library folder or subfolder that contains the video and image objects that you want to add to the movie project. Click and select the file. Click the "Open" button in the file browser window to add the image or video object to the Movie Maker storyboard pane. If you also want to add an audio track to the movie, click "Add Music" in the "Add" group and follow the same procedure to import the audio object.
Click an image, video or audio object in the Movie Maker storyboard pane. Single-clicking the object highlights the item so that you can edit or add visual effects to the object. When highlighted in the Movie Maker storyboard pane, the object displays a pale blue border instead of no border. Movie Maker will apply any edit or visual effect that you now select to the highlighted object.
Click the "Animations," "Visual Effects" or "Edit" tabs in the main menu ribbon. Select your preferred edit or effect from the items available in the toolbar groups on each menu tab. You can add transition effects to smooth the join between two objects, or select a visual effect that changes the appearance or stylizes the image or video object. Once you've highlighted and edited one object, click another object to highlight it and follow the same procedure to add an effect.
Click "File" in the main menu. Select "Save Project" to save the project, or "Save Movie" to save the project as a movie file on your computer.
Tips & Warnings
- Highlight multiple objects at the same time by holding down the "Shift" key on your computer keyboard and clicking on each object that you want to highlight and select.


text:
Definitions of hackney
n. - A horse for riding or driving; a nag; a pony.
n. - A horse or pony kept for hire.
n. - A carriage kept for hire; a hack; a hackney coach.
n. - A hired drudge; a hireling; a prostitute.
a. - Let out for hire; devoted to common use; hence, much used; trite; mean; as, hackney coaches; hackney authors.
v. t. - To devote to common or frequent use, as a horse or carriage; to wear out in common service; to make trite or commonplace; as, a hackneyed metaphor or quotation.
v. t. - To carry in a hackney coach.
The word "hackney" uses 7 letters: A C E H K N Y.
No direct anagrams for hackney found in this word list.
Words formed by adding one letter before or after hackney (in bold), or to acehkny in any order:
s - hackneys
Shorter words found within hackney:
ace ache achy acne ae ah an ane ankh any ay aye cake cakey caky can cane cay chay cyan each eh en ha hacek hack hae haen hake hance hank hanky hay he heck hen hey hyena ka kae kane kay kea ken kench key khan na nae nah nay ne neck ya yack yah yak yank ye yea yeah yean yech yeh yen
List shorter words within hackney, sorted by length
Words formed from any letters in hackney, plus an optional blank or existing letter
List all words starting with hackney, words containing hackney or words ending with hackney
All words formed from hackney by changing one letter
Other words with the same letter pairs: ha ac ck kn ne ey
Browse words starting with hackney by next letter
Previous word in list: hackmen
Next word in list: hackneyed
Some random words: iodate ex ajee oblong dakerhen huarache ctenidia
This is not a dictionary, it's a word game wordfinder.
- Help and FAQ - Examples - Home
Privacy and Cookies Policy - Share - © Copyright 2004-2017 Morewords.com - 47.825mS


text:
The following is a guest post by Meredith Franco Meyers.
Whoever said, "It's not a free show," wasn't touring London!
Sure, many savvy budget travelers know that London's major museums, like the British Museum and the National Gallery, are free most any day of the week.
But during the time we've spent hunting down London's budget hotels, we've also picked out a few out-of-the-ordinary museums that aren't always on backpackers' radars. So, read on and then plan to browse with the best of 'em while holding on to those extra pounds.
1. Museum of London
- Address: London Wall, EC2Y 5HN
- Tel: 020 7001 9844
- http://www.museumoflondon.org.uk
Ever wonder what London looked like during Roman times?
In nine permanent—and entirely free—galleries at the Museum of London, visitors get the skinny on life pre- and post-Kate-and-Wills and much more. From prehistory to Elton John and a recent special exhibit on Dickensian London, this place is a must-see. Talk about great expectations!
Bonus: When you've finished touring the place, take a look in the gift shop. Or, visit one of the on-site restaurants. The London Wall Bar & Kitchen has a great outdoor terrace that's a solid pick during warmer months.
2. Wellcome Collection
- Address: 183 Euston Road, NW1 2BE
- Tel: 020 7611 2222
- Hours: Closed every Monday (open on Bank and public holidays), open Tuesday through Sunday (hours varied)
- http://www.wellcomecollection.org/
What do Napoleon's toothbrush, George III's hair and the Virgin Mary all have in common? (No, this is not the beginning of a joke.)
They are all items in the unique Wellcome Collection in central London. Sir Henry S. Wellcome, an American-born aristocrat who made his way to London and later became a British knight, was an aficionado of the arts and sciences. As such, he amassed plenty of interesting objects and curiosities, now on display to the public.
There's lots to write home about here and many free daily guided tours. Current exhibits include, "Medicine Man." It's a giant room filled with Wellcome's artifacts related to pharmacy, medicine and scientific advancement (and where you'll see George III's hair and Napoleon's toothbrush).
3. Sir John Soane's Museum
- Address: 13 Lincoln's Inn Fields, WC2A 3BP
- Tel: 020 7405 2107
- Hours: Tuesday to Saturday 10 a.m. to 5 p.m.
- http://www.soane.org
Sir John Soane (b. 1753-1857) was a professor of architecture at the Royal Academy and the man responsible for designing the Bank of England.
Housed in his former residence, a noble brick townhouse in central London, Soane's fascinating collection of artifacts and personal effects were gathered from the 1780s to the 1830s and are now on display for free! The permanent collection ranges from architectural plans for the Bank of England and the Royal Hospital Chelsea.
A recent exhibit also showcases miniature plaster versions of iconic buildings. Did somebody say "little pantheon"?
4. Ragged School Museum
- Address: 46-50 Copperfield Road, E3 4RR
- Tel: 020 8980 6405
- Hours: Wednesday and Thursday 10 a.m. to 5 p.m., first Sunday of the month 2 p.m. to 5 p.m.
- http://www.raggedschoolmuseum.org.uk
Visit Dr. Barnardo's former Ragged School in Mile End and discover how he managed to educate and feed multitudes of poor East End children.
Through a series of canal-side rooms, visitors get a glimpse of Victorian living. Top-floor rooms witness everyday scenes of life under Queen Victoria's reign while ground level spaces give a detailed and absorbing history of the East End in general.
Best of all are the interactive sessions in the first-floor classroom, where "pupils" of all ages sit at old-fashioned wooden desks—complete with chalk and slate—while a stern teacher, dressed in period garb, puts them through the paces.
5. Museum of Childhood
- Address: Cambridge Heath Road, E2 9PA
- Tel: 020 8983 5200
- Hours: Monday through Sunday from 10 a.m. To 5:45 p.m.
- http://www.vam.ac.uk/moc/
Encompassing a variety of small exhibits (no pun intended) on the histories of children from various civilizations, the Victoria and Albert's younger sibling museum is situated in a series of houses in London's Bethnal Green neighborhood.
The name of the institution speaks for itself and throughout a series of free exhibits you can learn about childcare, toys, child labor through the ages and lots more.
Want to know the history of the Rubik's Cube? Ready to check out a baby potty seat from 1820? Then, you're in the right place.
About the Author: Meredith Franco Meyers writes and edits for EuroCheapo.com, a leading budget travel site. She has written for American Baby, SELF, Ladies' Home Journal and more. She is on the faculty at the Gotham Writers' Workshop in New York City.


text:
Sunday, October 28, 2012
Painted Print
I had to render a monotone floral print and I had a good idea how I would do it before I even started. Of course, things don't always go as you plan. Fortunately, what I did wasn't too far from it, and although I did tool with the extent and intensity of the color, I think it both looks like the original as well as works as an illustration. I'll post the full sketch when I finish the series. I rather liked how the hair turned out.
Saturday, October 27, 2012
Leg Work
The other part of yesterday's drawing. I do a quick sketch first, then start ot clean it up, then paint in colors, then erase some of my original pencils and draw newer ones that have a bit more definition to them... all the while trying to make them look like, "oh, I just spontaneously painted everything with no effort at all". I don't know if I succeed, but I'm often told my linework looks very confident and immediate, so there's that.
Friday, October 26, 2012
Facial Recognition 2
If I do my job right, the coloring works without much effort. So far it seems okay, just tweaking here and there. Progressing...
Thursday, October 25, 2012
Facial Recognition
I love doing portraits, and I love getting a likeness. But because I pride myself on it, I fight myself so much when I strive to perfect the likeness. And it's something that never happens easily for me when I really want to get a good semblance. I'm not one of those photographic illustrators who can reproduce a photo with astounding accuracy - my hand will always show through, my tendencies in line and form will often give a semblance flaws... although in other people's eyes, that's my style. But I still try and I think I get successful more than not. So here I am, working on a new sketch/portrait. It's sometimes even harder when I'm sketching pencils in because I know I have to build it up with color and another 'medium' and the pencils don't need to capture all the data because other elements will fill it in later...
Wednesday, October 24, 2012
Golden Skirt
I'm planning on being done with this magazine cover commission and delivering it tomorrow. I always thought I would finalize it just when everything was ready on the agreement side, as well as from the layout side, and it all is. So now I'm just touching up on details, cleaning up lines and excess pixels, and otherwise simplifying the tones while trying to leave a sense of immediacy as well.
Tuesday, October 23, 2012
Tank Ewe...
...Berry Mush. One of my best friends' boyfriend treated us to a performance of Pina Bausch's last work, at the BAM theatre this evening. I knew nothing about the artist, and was pleasantly surprised. I even got called to the stage for a bit of audience participation! So this is my little thank you drawing for Charles. Tank Ewe!
Monday, October 22, 2012
White Suit 2
This figure was stymieing me, because beside the colorful outfit this model was paired with, it just looked blah and unworthy of attention. Plus the model who wore it is more of a quirky type, so in my interpretation he comes across as more everyman. Funny how, after I tried to bolster the image with additional colors and techniques, what it took was for me to eliminate the figure next to him and post him solo, and I liked what I did much more.
Sunday, October 21, 2012
October Meetup
Went to the monthly Fashion Model Drawing Meetup I attend. I was having a bad morning (actually a bad week) and was annoyed at everything today: my elevator man, my neighbors, work. Fortunately I was able to just turn off and draw almost on automatic.
When my sumi brush kept splaying and sending stray lines of paint on my work, I had to abandon my (admittedly decades old) favorite brush and try to work enough control with the new brushes. These new brushes take some getting used to, and I think I may enjoy working with them but it'll take some time to learn to control it. Fortunately today became a good practice session with the new brushes.
When my sumi brush kept splaying and sending stray lines of paint on my work, I had to abandon my (admittedly decades old) favorite brush and try to work enough control with the new brushes. These new brushes take some getting used to, and I think I may enjoy working with them but it'll take some time to learn to control it. Fortunately today became a good practice session with the new brushes.
Saturday, October 20, 2012
White Suit
Friday, October 19, 2012
Makeup Makeover
Thursday, October 18, 2012
Dolled Up 2
For some reason I completely forgot about drawing today, which is weird because I didn't have a ton of work to get through, just a lot of planning. Funny how having too much time on my hands results in not enough time.
Anyhow, for lack of a better project, I did two more outfits on my ex trainer's paper doll.
Anyhow, for lack of a better project, I did two more outfits on my ex trainer's paper doll.
Tuesday, October 16, 2012
Dolled Up
It's my ex trainer's birthday today and he had once asked me if I would do a super sexy cartoon of him. I had already done one 'toon version of him back around post # 678 (we're at #1960 right now on this blog) so I thought it might be fun to do the skimpy versions with options for coverups! And that flasher outfit? That was his costume for Halloween last year.
Monday, October 15, 2012
This is a rough rendering of another section of the cover illustration I'm working on. I wondered if it was a bit too comic book in style, but with the other element of the page (which doesn't really count as drawing in my book, so I won't show it here) it kinda worked. PLus I only had so much time on it, and the initial color exploration didn't quite work out...
Sunday, October 14, 2012
Give 'em the Bird 2
I wasn't satisfied with the rendering I used and tried multiple times for a more Victorian look in line with the period costume. So I tried to make the bird a tad more realistic, but still am undecided about how to render it all. I think this job would have been better served had I done a collage, but we'll see...
Saturday, October 13, 2012
Give 'em the Bird
Taking a mandatory break from all the fashion illustrations to do a commission I had been asked to do over a month ago. I came up with a concept I knew that I could do well, but the funny thing is that I didn't have the full approach for how I was going to render it until just yesterday! So here's a rendering-in-progress of one of the elements of the commission.
Friday, October 12, 2012
I was working on getting my fashion illustrations together for uploading, and it took much longer than I thought it would. So all I want to do tonight is something flowy and easy. And here she is, all fwooshy... I think she took all of 6 minutes to do (yeah, it shows, but I do like the attitude).
Thursday, October 11, 2012
Working The Angles 2
I started thinking that I while I was really happy with the drawing, I wanted to make it resemble the model more. So I think it went from fashion illustration to portrait. I can't help myself - I love getting a likeness... and I'm really not used to drawing profiles like this so it's a definitely a learning experience.
Wednesday, October 10, 2012
Working The Angles
Tuesday, October 9, 2012
Face Protection
Backstage before they put some of the tops on, they would cover the models' faces with fabrics to protect the hair and makeup. At this particular show the fabrics they used actually matched their outfits, with dark protectors for dark looks, and lighter ones for lighter outfits. I thought they looked pretty editorial as well, resembling origami-esque accessories.
Monday, October 8, 2012
Tevas! 2
Sunday, October 7, 2012
Drunken Posting
I was out with an old high school classmate, Mike, and we lost track of time just chatting and having drinks. Six hours of socializing, to be exact. So if my drawing is somewhat arbitrary, it's because i can barely type as is!
This is a makeup drawing for last night/yesterday (late, two days in a row!). Friends of mine had their gay wedding last night, and as his unofficial stylist and invitation designers, I ended up more involved in his prep than I realized. Plus weddings take all night anyhow, and between the getting ready and the actual event, I didn't get home til after midnight.
But I was shopping a vintage clothing site and a shot of a model had a nice swoop to it, although I emphasized it more in my sketch to really give it a lot of S curve counterpoint.
But I was shopping a vintage clothing site and a shot of a model had a nice swoop to it, although I emphasized it more in my sketch to really give it a lot of S curve counterpoint.
Saturday, October 6, 2012
I got home too late to post something for yesterday, so this is October 5th's post. I had cooked dinner at a friend's place and we all watched "Cabin In The Woods" afterwards, and they all hated it (the movie - my cooking was a hit)! I don't understand, but I suppose I'm still a geek at heart. Well, had I not lived in hope that they would like it, I would have been home earlier. I ended up surfing through a few blogs and getting inspired by the very minimalist yet especially nuanced work of Kevin Wada. I just love how his characters have a very relaxed, real and yet fashionable air about them.
Thursday, October 4, 2012
Among the (suddenly I realize) many projects I'm doing concurrently, I have to design some non-denominational holiday cards. I've done this for this client several times before, and it really tests my creativity to do something I think is graphically cool, but in the style they like (MoMA cards), and not religiously restrictive. So how's a fox in the snow? (Kitsune, for those who don't know, is 'fox' in Japanese)
I also made some blue jay and cardinal drawings, which I think turned out reeeally cute! That cardinal looks kinda mean hehe.
I also made some blue jay and cardinal drawings, which I think turned out reeeally cute! That cardinal looks kinda mean hehe.
Wednesday, October 3, 2012
Get In Line 2
I'm really still figuring out how to do this in Photoshop. Do I try to emulate watercolors which is not that intuitive? Or do I find my own style in Photoshop that just happens to look like watercolors? I think I'm doing a little of both, making it up as I go along.
Tuesday, October 2, 2012
Bryan and his friend Heron
Bryan and his friend Heron were just glad they didn't get run over by the wayward delivery truck... or so they thought.
Monday, October 1, 2012
Getting Dressed
Subscribe to:
Posts (Atom)


text:
Payscale.com recently ranked U.S. colleges based on return on investment (ROI) over high school graduates, that is how much more college graduates earn than high school graduates on average over a span of thirty years minus the cost for college attendance.
The figures are calculated with voluntary reports from graduates who did not seek post-graduate education, and they extrapolate from the past. If a school has recently changed its offerings profoundly, the numbers may be misleading. The ROIs are adjusted for length of study, drop-out rate and inflation. Costs for interest accrued on student loans are not included.
Payscale.com's list is ranked by thirty-year net ROI. The top ten exclusively consist of private institutions of higher learning. Prestigious engineering schools are in the lead. This is not surprising, because engineers seek post-graduate degrees less frequently than graduates with other majors and draw high salaries. Ivy League members constitute half of this group.
More intriguing, however, is the ranking by annual ROI (table below). This number represents the average return per year as percentage of the cost of college attendance. Only one private school can be found among the top ten of this list. The rest are public schools. In-state students garner the best return for their investment. Taking the high cost of student loans for private institutions into consideration, good public schools undoubtedly offer the best deal economically.
Colleges Worth Your Investment - Top Ten by Annual ROI
School Name | School Type | Average Cost for College & *Fed. Loan Debt in '09 [$] | 30 Year ROI [2010 $] | Rank | Annual ROI [%] | Rank |
Georgia Institute of Technology | Public (In-State) | 79,140.- *16,210.- | 1,111,000.- | 31 | 14.2 | 1 |
Brigham Young University | Private | 58,450.- *12,278.- | 797,000.- | 77 | 14.1 | 2 |
University of Virginia | Public (In-State) | 74,410.- *24,582.- | 1,038,000.- | 38 | 14.1 | 3 |
College of William and Mary | Public (In-State) | 74,720.- *22,755.- | 895,000.- | 51 | 13.6 | 4 |
Colorado School of Mines | Public (In-State) | 95,740.- *15,856.- | 1,132,000.- | 27 | 13.6 | 5 |
Virginia Polytechnic Institute and State University | Public (In-State) | 83,270.- *15,660.- | 854,300.- | 62 | 13.1 | 6 |
University of Michigan | Public (In-State) | 84,690.- *20,458.- | 875,400.- | 58 | 13.1 | 7 |
University of California at Los Angeles | Public (In-State) | 94,100.- *21,277.- | 961,200.- | 47 | 13.1 | 8 |
University of California, Berkeley | Public (In-State) | 118,900.- *17,054.- | 1,223,000.- | 16 | 13.1 | 9 |
University of North Carolina at Chapel Hill | Public (In-State) | 61,830.- *23,125.- | 615,100.- | 149 | 13.0 | 10 |
- State prepaid college tuition and fees plans, also known as 529 college savings plans, are designed to pay towards tomorrow's college tuition and fees at today's price, plus provide a tax rebate. Considering the steep rise of tuitions and fees at public schools in the past decade alone, the plans seem a sensible choice for parents to keep their children's student loan debt low. However, as Jessica Toonkel and Jilian Mincer report in their post with the title "Prepaid college plans: shrinking options, rising risks" published online on Reuters today, some plans have lost on investments, are underfunded and may fall short in their promises, despite legislative guaranties. Regardless, the Virginia529 College Saving Plan appears to be one of the safest, providing an additional benefit to students at the University of Virginia, the College of William & Mary and other institutions of higher learning in this state (01/11/2012).
- Alan Silverleib and Tom Cohen, report a new higher education initiative of the Obama administration aimed at improving outcome in their article with the title "Obama unveils plan to control college costs" published online on CNN today. The President announced the reform at the University of Michigan, which is on the top ten list above. Hopefully, this overhaul will benefit students at good public schools (01/27/2012).
- Stephanie Simon reports in her post with the title "U.S. college ratings game set for shakeup" published online on Reuters yesterday that the recent scandal surrounding falsely reported SAT scores at Claremont McKenna College, a the prestigious private college on the West Coast, may deeply affect how institutions of higher learning are judged in this country (02/04/2012).
- Jack Hough's insights in his article with the title "'Investing' in College? It Pays to Think Like an Investor" published online by The Wall Street Journal yesterday are well in tune with the thoughts in my post (05/05/2011).
- Based on a student survey conducted by ratemyprofessors.com, Robert Franek, Laura Braswell and the staff of The Princeton Review compiled a list of the 300 best professors at US institutions of higher learning along with professor and school profiles. The list was published in softcover by Random House this year and is quite informative. For example, Harvard University (private; annual tuition: $34,976.-) contributes two professors to the list. By contrast, The College of William and Mary (public; in-state tuition: $13,132.-; out-of-state tuition: $35,409.-) is home to ten such professors (05/23/12).
- Anna Prior and Matthew Heimer's article with the title "Which colleges help grads snare top salaries?" published online by marketwatch.com yesterday completely affirms the basic conclusion of my post that good public schools deliver most bang for the buck (09/26/2012).


text:
Massage Central London
Massage in Central London – Want to Be Better at Back Massage?
Everybody wants to get a massage but not everybody is okay giving them to another person. We're frightened of unintentionally causing hurt to the other person. Also, it's possible to feel afraid that the massage may not be good enough. We get afraid that other people won't appreciate what we are trying to do. You will be glad to find out that any person can learn how to give a great massage each time they want to do just that. The following are a few tips on how to give an impressive back massage.
To start off, see to it that the person is comfortable while lying down. Firm and soft are what you want when it comes to the surface on which they are lying down. You don't need a massage table table but you might have them lie down on a bed. If they are on your floor, place a mat or some soft blankets or towels so that they will feel more comfortable. If the massage-ee wishes to keep his or her shirt on, be sure that the shirt is made of a softer material to avoid accidental chafing and friction build up.
Begin with some standard rubbing. Using the enture flat side of your hands, rub gradually up from the lower back area toward the neck. This rub must have at least a little bit of pressure in it but don't use your full massage pressure yet. Begin at the base of the person's back and then glide your hands up the back then across the shoulders and then back down the back. As you keep doing this, make your loops smaller and smaller so that you are able to cover all areas of the back.
Try using the heels of your hands to generate good and pointed pressure. Using the heels of your palms to apply pressure, begin working in small circles at the base of the back on either side of the spinal column and then work those tiny circles out toward the person's sides, up a little bit and then back across to the spinal column and upward until you have massaged the entire back.
Try to sit on one side of the individual who is getting your massage. Then, putting one hand on top of yor other hand, push into the back using your fingers. Begin with the spinal column and dig in steadily away from the backbone, across your back and then very lightly rub your hands back toward the backbone. Repeat this process as you work up the back and then do the same thing on the person's other side.
Rub the spinal column. Beginning with the base of the spinal column, work your way up each of the sausage like sinews on either side of the backbone by rubbing in small circles with a couple of fingers or your thumbs. Knead each node at least five times each so that you can build up some friction. Massage one side of the spinal column and then the other.
Something that you have to bear in mind as you use these massage techniques is that it is good to re-relax the person between each part of the massage that you give. This means that after you've used one technique, do the basic rub that you used at the beginning of the massage for a few minutes.


text:
> home > Products > Primary Antibodies > Antibody Collections > GPCR Antibodies > Anti-REN / Renin 1 Antibody (aa131-406, clone 1D3)
Anti-REN / Renin 1 Antibody (aa131-406, clone 1D3)
Mouse Anti Human Monoclonal Antibody
Primary Accession | P00797 |
Predicted | Human |
Host | Mouse |
Clonality | Monoclonal |
Isotype | IgG2a |
Clone Names | 1D3 |
Calculated MW | 45057 Da |
Dilution | IHC-P (10 µg/ml), WB (1:500) |
Gene ID | 5972 |
Alias Symbol | REN |
Other Names | REN, Angiotensin-forming enzyme, Angiotensinogenase, HNFJ2, RENAA, Renin precursor, renal, Renin |
Target/Specificity | Human REN / Renin 1 |
Reconstitution & Storage | Immunoaffinity purified |
Precautions | Anti-REN / Renin 1 Antibody (aa131-406, clone 1D3) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | REN |
Function | Renin is a highly specific endopeptidase, whose only known function is to generate angiotensin I from angiotensinogen in the plasma, initiating a cascade of reactions that produce an elevation of blood pressure and increased sodium retention by the kidney. |
Cellular Location | Secreted. Membrane. Note=Associated to membranes via binding to ATP6AP2 |
Research Areas
Citations (0)
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
Submit your citation using an Abgent antibody to
firstname.lastname@example.com, and receive a free "I Love Antibodies" mug.
email@example.com, and receive a free "I Love Antibodies" mug.
Application Protocols
Provided below are standard protocols that you may find useful for product applications.
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.
$ 395.00
Cat# ALS18223
Ordering Information
United States
AlbaniaAustraliaAustriaBelgiumBosnia & HerzegovinaBrazilBulgariaCanadaChinaCroatiaCyprusCzech RepublicDenmarkEstoniaFinlandFranceGermanyGreeceHong KongHungaryIcelandIndiaIndonesiaIrelandIsraelItalyJapanKoreaLatviaLithuaniaLuxembourgMacedoniaMalaysiaMaltaNetherlandsNew ZealandNorwayPakistanPolandPortugalRomaniaSerbiaSingaporeSlovakiaSloveniaSouth AfricaSpainSwedenSwitzerlandTaiwanTurkeyUnited KingdomUnited StatesVietnamOthers
USA Headquarters
(888) 735-7227 / (858) 622-0099 or (858) 875-1900
Other Products
Shipping Information
Domestic orders (in stock items)
Shipped out the same day. Orders placed after 1 PM (PST) will ship out the next business day.
International orders
Contact your local distributors


text:
How can I make a relative path from my root folder to a subdomain?
Say that I link my css with this path (css/style.css)
How can I link the same stylesheet location relative like I did above?
Results 1 to 3 of 3
Thread: Relative Path
Thread InformationUsers Browsing this ThreadThere are currently 1 users browsing this thread. (0 members and 1 guests) |


text:
then I saw this: http://www.youtube.com/watch?v=LOsgHYFvVxI
that's alot of tea!!
Login or sign up to post a message.
That was neat to see. I've wondered how mass production worked for such teas.
That's pretty crazy
That's pretty intense.
Wow, that's a wicked system! So well automated and precise.
Login or sign up to leave a comment.


text:
Games | Play free online games! |
>Matching Patterns
Matching Patterns
Play with your own profile by registering yourself for this fun game. You can also play as guest, but your scores and account will not be saved then.
User name / E-mail address...Password...Forgot password?
Not all required fields were filled in
User unknown
Matching Patterns
What do you think of this game?
Score: - (0 votes)
Matching Patterns is a variation of the famous mahjong game. Start from scratch or choose your level, pairing up identical shapes. To form a pair, the blocks must be adjacent or have a clear path on at least one side.Controls
Use the mouse to play |


text:
Degree Requirements
Students are required to master a series of core courses, advanced elective courses, seminars, and laboratory rotations. These serve as an interdisciplinary base for the development of dissertation research and usually occupy the bulk of the first two years in the program. Dissertation research (including data analysis and writing) typically requires an additional three years to complete. Your degree will be awarded upon satisfactory completion of all credit requirements and acceptance of your written dissertation by your committee.
Waiver of Program Requirements
Students may petition to be exempted from part of the curriculum, usually by scoring a passing grade on an appropriate proficiency examination. Students with a master's degree in a relevant field of study will be exempted from appropriate course requirements.
Students may also petition for waiver of credit for previous graduate courses taken in another accredited program. Advanced course credit of up to 6 credit hours may be waived providing all of the following conditions are met:
- The grade attained in each course is a B or better.
- The course was taken within four years of the actual waiver.
- The course relates to the area of concentration chosen in this Program.
Petitions for obtaining credit for laboratory experiences may be made, subject to the same credit hour limitations and time constraints as for courses.
Petitions for exemption or waiver should be submitted to the Program Director. Acceptability of course waivers will be determined by the Interdisciplinary Review Committee.
Starting in Fall 2012 Semester
The following is an example of a program of study for an Environmental Sciences Ph.D. student. Students establish the details of their program of study in conjunction with their supervisory committee.
Course Number | Course Title | Credit Hours |
Foundation Courses | ||
ES 7140 | Environmental Statistics | 3 |
ES 7090 | Perspectives in Environmental Science Seminars | 1 (2 total) |
(Choice of two of the following core courses) | ||
ES 7120 | Environmental Biology: Genes, Organisms, and Ecosystems | 3 |
ES 7160 | Complexity in Environmental Systems | 4 |
ES 7180 | Environmental Chemistry | 3 |
ES 7020 | Biogeochemical Cycles | 3 |
Subtotal | 11 or 12 | |
Advanced Electives | 10 (minimum) | |
Course Total | 21 or 22 | |
ES 7990 | Independent Topics & Research | variable |
ES 8080 | Internship Option | 10 (minimum) |
ES 8130 | Dissertation Research | 30 (minimum) |
Total | 90 |
Requirements are subject to change. Check with the Program Director.
A Ph.D. is a research degree. Each student must produce a dissertation that represents a substantial contribution to environmental science. For most students, completing the Ph.D. is a full time occupation that requires at least five years to complete.
In addition to the primary dissertation advisor, a dissertation committee is formed to periodically review the student's progress. The relationship between the student, the faculty advisor, and the committee is central to the Program. The committee determines when the research may be considered complete and must approve the written dissertation, as well as the student's public defense of it. The committee certifies to the Program Director the competency and achievement of the dissertation.


text:
Browsing Recipes similiar to Curried Tofu-Egg Salad Sandwiches.
Coconut Curried Tofu with Green Jasmine Rice
This is a vegetarian dish from Bon Appetit January 2003
curry powder, tofu, cilantro, green onion, +cherry tomato, +red pepper, +ginger, +lime juice, +garlic, +cumin, +rice, +coconut milk, +peanuts, +salt, +flaked coconut, +vegetable oil, +water
www.recipezaar.com - Similiar recipes
Coconut Curried Tofu with Green Jasmine Rice
curry powder, tofu, green onion, +cumin, +red pepper, +garlic, +rice, +coconut milk, +lime juice, +peanuts, +salt, +vegetable oil, +water
www.epicurious.com - Similiar recipes
Curried Noodles with Tofu
tofu, green onion, cilantro, +pasta, +coconut milk, +sugar, +soy sauce, +ginger, +garlic, +curry paste, +salt, +nonstick cooking spray, +red pepper, +chinese cabbage
find.myrecipes.com - Similiar recipes
Curried Parsnips
curry powder, yogurt, green onion, cilantro, +parsnip, +butter, +onions, +vegetable broth, +black pepper
recipe.aol.com - Similiar recipes
Curried Squash and Sweet Potato
A delicious recipe in a healthy, delightful curry sauce
curry powder, tofu, yogurt, green onion, +yellow squash, +vegetable oil, +enoki mushrooms, +garlic, +sugar, +sweet potato
www.recipezaar.com - Similiar recipes
Red Curried Tofu
curry powder, tofu, cilantro, +rice, +dark sesame oil, +red onions, +yellow bell pepper, +coriander, +turmeric, +salt, +soy sauce, +honey, +chile paste, +tomato, +cashew
find.myrecipes.com - Similiar recipes
Chilled Curried Pinto Bean and Gingered Carrot Soup
curry powder, yogurt, cilantro, green onion, +vegetable oil, +onions, +carrot, +ginger, +pinto beans, +chicken broth
www.bigoven.com - Similiar recipes
Curried Cucumber Dip
yogurt, mayonnaise, curry powder, green onion, +sour cream, +cumin, +salt, +red pepper flakes, +cucumber, +radish
find.myrecipes.com - Similiar recipes
Can't find what you are looking for? Try our custom google recipe search:
Custom Search
Your Ingredients:
Legend: click ingredients to include or exclude
have this
need to use this
exclude this


text:
Wall Street
NEW YORK (AP) — The stock market staged a late-day rally Monday, helping push the Dow Jones industrial average higher for the first time in a week.
Investors had a couple pieces of positive news to get behind: a decent earnings report from Berkshire Hathaway and the announcement of a rescue package for a struggling Portuguese bank.
However, investors remain cautious after last week's sell-off. Last week's market rout, where the S&P 500 fell nearly 3 percent in five days,…


text:
This blog provides updated forecasts and comments on current weather or other topics
Wednesday, June 26, 2013
Major Warm Up Ahead
The latest 6-10 day temperature forecast from the Climate Prediction Center says it all: well above normal in the west, with the most anomalous warmth (dark red) over eastern Washington and Oregon.
The origin of both our current cool/wet pattern and this weekend's warmth is essentially the same: a perturbed upper level flow pattern. Let me explain. The upper level (500 hPa) flow pattern today (at 2 PM, see below) had a VERY deep low over the eastern Pacific and a ridge of high pressure over the Rockies and western Plains. This left the Northwest in strong, moist southwesterly flow that brought the showers and clouds (remember the winds are parallel to the height lines and strong winds are associated with large gradients in heights--closer packing of the lines).
By Friday afternoon, both the low center and the ridge move westward, and the ridge builds in amplitude. Expect substantial improvement.
By Monday the flow pattern is really perturbed and "high amplitude" as we call it in the weather biz. The ridge will then be just west of the Rockies and the flow over the northwest will be weak and from the south. A warm pattern for the region.
This strange upper atmospheric pattern continues into Tuesday. The building of high pressure over our region is associated with clear skies, little precipitation, and warming. This particular pattern will bring the highest temperatures east of the Cascade crest (to get record warmth over western WA the ridge would have had to be centered farther westward).
The UW WRF model is going for a nice warm up by Friday (see graphic), with temperatures reaching into the low-80s over SW Washington and low 90s in eastern Washington.
Sunday at 5 PM, a bit warmer in eastern Washington.
But then on Monday, western Washington and Oregon, start ramping up, with highs up into the 80s in western Washington, 90s into the Willamette Valley and around 100F in the warmer portions of eastern WA.
And Tuesday will probably be even warmer...enjoy.
6 comments:
- SkywarnPierce4 said...
Looking at the extended GFS, sure looks like a lot of CAPE around N. California up thru W. Oregon. I wonder if we're going to have a little light show after the heat wave. I know it's too far out to get hopes up though but a storm spotter can hope. :-)
- June 27, 2013 at 12:51 AM
- Craig said...
My concern is we will have a major marine push on the 4th or a trough come in as this seems to be a cycle around here after a big heat up like that. Sadly, it would be right on the 4th making for a very dreary, cool and possible wet day. Horrible timing in my opinion!! :(
- June 27, 2013 at 3:39 PM
- Karl Bonner said...
We're also going to have a lot of HUMIDITY during this heat wave due to 1) all the rain we just had both sides of the Cascades, and 2) little to no east wind to dry out the lower atmosphere.
- June 27, 2013 at 9:14 PM
- Beno said...
Is it just me, or does anyone else think it's odd that these "strange" and "unusual" gigantic upper-level ridges in the eastern Pacific are in fact becoming 'usual'? Evidence of increasing global climate change/chaos?
- June 28, 2013 at 9:58 AM
- Buddy said...
Those were two good points left above. The WRF-GFS continue to put CAPE values in the 2000 to 3000 range for parts of the PNW. That's unusual. Wonder if its overestimating something like dew point etc....
But if you look at the column integrated water vapor, there's a lot of residual moisture sticking around with maybe an influx off south of Cali.. Maybe hot and humid. Again unusual relatively speaking.
Heard there will be a lack of tstorms due to a strong CAP? So there's cape and cap. It'd be awesome if you could explain more about our scenario. - June 28, 2013 at 10:56 AM
- patrick said...
CAPE ( convective available potential energy ) and Cap ( a lid on the upper levels ) @ 700mb the air will be very warm and limiting the potential for lift, unless decent forcing can occur thus compensating for the inability to break through the very warm layer up above. Think of the cap like a lid on a pot, the steam rises in the pot but the lid prevents the steam from rising beyond the lid and the same principle is at play here.
We need good forcing for any storms ( likely high based ) to bust through that cap.
Basic explanation and I'm sure professor Mass will go more in-depth on this. - June 28, 2013 at 2:15 PM


text:
Crank Brothers Kronolog Seatpost RecycledRecycled items have imperfections or suffered wear during the course of sale here at Chain Reaction Cycles. They include Ex-Display, Ex-Demo, Cosmetic Damage or Refurbished items that have been returned by customers, repaired by suppliers or have scratches or minor damage from transport or display STATUS: EX-DEMO Item was fitted to a CRC charity event bike Seatpost has been serviced prior to sale Shows cosmetic scuffing and scratches to lower section of post Shows cosmetic paint rubbing to saddle clamp area Any damage is purely superficial & does not affect performance May show signs of handling & storage Fully inspected prior to sale*** Please note remote cable and lever included ***Crank Brothers Kronolog Seatpost All new adjustable seatpost from Crank Brothers - 125mm of infinite adjustment. Mechanical design - hydraulic feel Features: Material: aluminum. Post length: 405mm. Weight: 465g 28g (30 9mm remote*) / 477g 28g (31 6mm remote*). Adjustment range: 125mm / 5in. Adjustment type: standard shift cable. Colour kits: clamp & lever colour kits available in gold, blue, orange (sold separately).
Check stock and price


text:
This is our website. Would you prefer to shop on our website? This is our website. You previously shopped on our website. Would you like to go to our website now?
Other country sites
My Account
My Bag
You are here:
Refine your evening ensemble with the Linda dress from Forever Unique. This bodycon style dress is designed with a round neck, long sleeves, bust cups and features a feminine floral lace and polka dot mesh front and arms finished with a subtle rear zip closure.
Product code: 651499
Exchanges & Returns We will happily offer an exchange or refund within 14 days of delivery. For full details please read our returns policy
Using the standard service, your order should be with you within 3-5 days.
International delivery is available for this product. The cost and delivery time depend on the country.
We use cookies to give you the best customer experience possible. If you continue to use our website, we will assume you are happy to receive cookies from us and our partners. More info


text:
Login Required
JPG+ Required
Collections are a JPG+ feature. You must be a JPG+ member to create new collections and to add photos to collections.
Sign up for JPG+ to start using collections now!
Photo license: © All rights reserved
My 3 yr old, Scarlett, showing me she climbed up and all by herself.
No responses


text:
1. Huntara
2. Queen Andreeno
3. Kittrina
4. Hawke/Delora
5. Queen Balina
6. Star Child
7. Princess Rana
8. Glimmer
9. Scorpia
10. Queen Angella
Honorable mentions: Snake Goddess, Celice, Snowflake, Ileena, Zilora, Hunga, Crita, Gorgone...
1. Huntara
2. Entrapta
3. Double Trouble
4. Shower Power Catra
5. Starburst She-Ra
6. Filmation Teela
7. Scorpia
8. Queen Teela
9. 200x Sorceress
10. Peekablue
You never change things by fighting the existing reality. To change something build a new model that makes the existing model obsolete
Buckminster Fuller
1. Huntara
2. Queen Andreeno
3. Kittrina
4. Hawke/Delora
5. Queen Balina
6. Star Child
7. Princess Rana
8. Glimmer
9. Scorpia
10. Queen Angella
Honorable mentions: Snake Goddess, Celice, Snowflake, Ileena, Zilora, Hunga, Crita, Gorgone...
1. Critta
2. Glimmer
3. Sweet Bee
4. NA Teela
5. Flutterina
6. Peekablue
7. Mermista
8. Angella
9. Entrapta
10. Madam Razz (& Broom!)
Where are the rest of my New Adventures Classics figures?!?!?
**Staunch FILMation lover!!! **** MUST complete the New Adventures Faction!!!**
MOTUC NEEDS more TROLLANS !!!
I.} Glimmer
II.} Scorpia
III.} Kittrina
IV.} Mermista
V.} Perfuma
VI.} Kowla
VII.} Clawdeen
VIII.} Peekablue
IX.} Zenia
X.} Illumina
Does Galactus fart?
2. Glimmer
3. Angella
4. Peekablue
5. Flutterina
6. Sweet Bee
7. Mermista
8. Entrapta
9. Double Trouble
10. Teela'Na (Pre-Sorceress)
"Live the journey, for every destination is but a doorway to another."
"If the connection ends up being Scott Neitlich sitting at his desk,
I'm gonna punch Scott in the face!" -JVS3 RGD Ep072
1. Despara
2. Angella
3. Glimmer
4. Crita
5. Huntara
6. NA She-Ra
7. Queen Teela
8. Veena / 200X Sorceress
9. Double Trouble
10. Entrapta
01 Mermista
02 Crita (original outfit)
03 Mara
04 Entrapta
05 Huntara
06 Mortella
07 Hunga
08 Sweet Bee
09 Kittrina
10 Hawke
We know Scorpia is coming, so didn't include her
MOTUC WISHLIST - Karg | Lady Slther | Kothos | Staghorn | Sorceress of Serpos Teela | Hunga the Harpy | Kittrina | Dylamug | Hawke | Angast | Zilora | Artilla | Quakke | Robo-Woman | Great Black Wizard | Enchantress | Red Beast | Delora | DC He-Man | DC Skeletor | Lodar | Fang-Or | Mini Comics Tri-Klops | Filmation Jitsu, Frosta & Kobra Khan | Hans Hammer Holder | Granita |
I already received a lot of female characterd that I needed (Shokoti! Shokoti! Yeah! Yeah!)....
But I need also these 10 (alphabetical order):
- Crita
- Delora
- Granita
- Hawke
- Horde Adora
- Huntara
- Julie Winston
- Light Spinner
- Perfuma
- Snake Goddess
The Snake Goddess thanks you!
Thank you for the support but she's is italian!
I know 2 angels: their names are Jedi_Kunle and Mikethedrummer!
Worship the Snake Goddess!
Now that all the vintage figures are done, don't let MOTUC die, keep buyin' the figures!
2016 will be great!!!
1. Glimmer
2. Queen Angella
3. Mermista
4. Double Trouble
5. Scorpia
6. Sweet Bee
7. Flutterina
8. Peekablue
9. Madame Razz
10. 200X Sorceress
Honourable mentions: Entrapta, Granita, Spinnerella, Huntara and Starburst She-Ra.
1. Scorpia
2. Sweet Bee
3. Mermista
4. 200X Sorceress
5. Queen Angella
6. Flutterina
7. Perfuma
8. Spinnerella
9. Peekablue
10. Entrapta
1. Peekablue
2. Mara
3. Glimmer
4. Entrapta
5. Zilora
6. Scorpia
7. Double Trouble
8. Crita
9. Queen Veena
10. Drissi
Peekablue is my absolutely most wanted.
Even though she isn´t part of my 10. MOST WANTED LIST i also want Mermista really bad and i so hope for Granita AND the female Rock Warrior from the mini comic!
*Toy version Catra *Sagitar *Drissi *Lizorr *Zilora *Granita *Delora *Battle Armor Queen Marlena *Hawke *Pebb-Liss(Minicomic Comet Warrior) *Lady Slither
Hunga the Harpee
Madam Razz & Broom
Queen Angela
Dree Elle
1. Peekablue
2. Huntara
3. Entrapta
4. Scorpia
5. Kittrina
6. Madame Razz & Broom
7. Perfuma
8. Flutterina
9. Spinnerella
10. Mermista
"You don't wanna beat me or screw me!? What kind of marriage is this? Bring a book." -- Jerri Blank to her pretend husband Ronnie Leggett, from "Strangers With Candy"
double trouble
1. Madame Razz
2. Entrapta
3. Scorpia
4. Spinnerella
5. Double Trouble
6. Huntara
7. Crita (1st version)
8. Drissi
9. Sweet Bee
10. Flutterina
More Vintage NA for MOTUC in 2017!!
MOTUC Top Ten Super 7 wants: KAYO, Hoove, Drissi, Crystoll, Chef Allen, any Catra variant, Quakke, Nocturna, Red Knight, Clawdeen (flocked)
Great .org transactions: sdilks, Man-E-Toys, bigassbuzz x2, Climan, wolvie3579, air23cnhit, Jestermon, Skystalker
Madame Razz w/Broom
Queen Angella
Sweet Bee
1. Seeress
2. Spydra
3. Spritina
4. Polti Queen
5. Mortella
6. Lady Irena
7. Majestra
8. Madame Wizz
9. Julie Winston
10. Snowflake
1. Scorpia
2. Madam Razz
3. Hunga the Harpy
4. Entrapta
5. Dree-Elle
6. Huntara
7. Glimmer
8. Angella
9. Mermista
10. Giant Gorgon
None of the Great Rebellion ladies are in here, because I fully demand they all get released, even if the line dies and Scott has to pump them out one at a time with his bare hands. This is just my list of desired off-shoot females, etc.
Sharella - I want a Pre-Goddess version of Sharella, based on the concept character for Powers of Grayskull - possibly styled after the bow-woman on Megator's Box Art (if no other basis for her design is in existance).
Kittrina - Carnivus needs his people represented, also Filmation
Huntara - bad aft doesn't come more correct than this. She's got a great 80s look, and she'd be a great addition to the line
Veena - A must-have character from MYP and Grayskull needs his woman!
Crita - because mreow!
Mara - I'm running out of wants
Illeena - She looks like a Valkyrie and it's such a great look that MOTU is missing - if she came out, I'd totally hook her up with Vikor (or Vykron) since she has that great Nordic warrior design. She's a one-shot background Filmation nobody, but her design is a savior.
Alcala Teela (Blonde hair)
Zilora - another Filmation Forgettable who has a unique design, like something out of a 50s Sci-Fi comic or Dr. Seuss.
200x Marlena - Because I'm out of actual wants - she would make a nice counterpoint to vintage Randor, having both of them ready for battle.
Last edited by Straight Edge; February 14, 2013 at 12:38pm.
Red Beast needs your support!
Please consider Red Beast, the MUST HAVE concept figure, when making your Wish Lists for Super 7!
1 Mermista
2 Glimmer
3 Queen Angella
4 Scorpia
5 Peekablue
6 Flutterina
7 Perfuma
8 Spinnerella
9 Entrapta
10 Sweet Bee
Madame Razz
Strange women dressed in bird outfits guarding castles distributing swords and harnesses in no basis for a system of heroism.
Madame Razz
Sweet Bee
Would have added Dragon Blaster Marlena if it wasn't against the rules. Lol.
Go big or go home
1. Perfuma
2. Glimmer
3. Angella
4. Sweet Bee
5. Spinnerella
6. Flutterina
7. Mara (2nd outfit -NOT the two-piece out-of-character prototype figure outfit)
8. Crita (First outfit)
9. Madame Razz
10. Granita
"Yep! And now I'm gonna blast ya!"
- Orko to Skeletor in "Lessons"
1. Despera
2. Illumina
3. Starburst She-ra
4. Mermista
5. Sweetbee
6. Sorceress Teela
7. Glimmer
8. Angella
9. Veena
10. Sharella
01 Celice
02 Mermista
03 Scorpia
04 Glimmer
05 Angella
06 Mara
07 Crita
08 Peekablue
09 Sweet Bee
10 Entrapta
The top five are pretty firm, but I'm probably forgetting other characters who could break into the bottom five.
Last edited by ShadowBeast; February 14, 2013 at 02:52pm.


text:
University of Texas-Austin President to Leave June 2015
Janet LorinUniversity of Texas at Austin President Bill Powers will step down as of June 2, 2015, after a years-long feud with the university system's chancellor and Board of Regents.
Powers, who has led the state's flagship public university for eight years, submitted a letter of resignation, which was accepted by Chancellor Francisco Cigarroa, according to a statement today on the system's website.
Powers, the board and Cigarroa have been at loggerheads for years. The battle stems from criticism by some regents that in an attempt to be a major research institution, the school has failed to focus on teaching the most students at an affordable cost. Cigarroa had demanded Powers's resignation last week, prompting faculty and alumni including former U.S. Senator Kay Bailey Hutchison to rally around him.
"There was no single incident that prompted my decision to ask President Powers for his resignation last week, but a long history of issues with communication, responsiveness and a willingness to collaborate," Cigarroa said in a statement.
Next month, board Chairman Paul Foster will initiate the search for a successor to Powers, and a committee will be set up that will include members of the faculty, deans, students and community representatives, according to the statement.
$3 Billion Campaign
Powers, 68, asked to remain on the job to lead the university through the next state legislative session and to make for a smooth transition, Cigarroa said. Powers is concluding a $3 billion capital campaign and helped establish the university's Dell Medical School as well as start construction on an engineering center.
"We worked hard to come up with this plan and it's a plan I am very happy with," Powers said in a phone interview today.
In 2011, Republican Governor Rick Perry called for state universities in Texas to offer degrees for $10,000. Many academics, including Powers, resisted the focus on cutting expenses. Since then, Powers and the regents have increasingly been in disagreement about the changes Perry called for and some regents supported.
"Higher education is really in a time of immense change," said Anne Neal, president of the Washington-based American Council of Trustees and Alumni, which represents college boards. "We certainly are seeing growing public concern about issues of quality and cost."
'Highest Honor'
The primary responsibility of trustees "is to the taxpayers and the people of the state and to the students," Neal said.
Powers, who served as dean of the law school before becoming president in 2006, spoke about his resignation today at a meeting of the Faculty Council.
"It has been the highest honor and the blessing of my life to be here," Powers said at the meeting. "It's the right time, for me and my family."
After taking some time off, Powers said he plans to teach at the law school and write books on legal philosophy and torts. He is currently also serving a year term as chairman of the Association of American Universities, which represents major research schools in the U.S.
An online petition supporting the embattled president had drawn more than 14,000 signatures, including from faculty members.
Powers and Cigarroa have placed the interests of the university ahead of their own individual interests, said Molly Corbett Broad, president of the American Council on Education, a Washington-based group of higher education institutions representing more than 1,600 college presidents.
"The University of Texas at Austin will recover from these difficult days," she said.


text:
Merck Announces Third-Quarter 2010 Financial Results
- Non-GAAP EPS of $0.85, Excluding Certain Items; GAAP EPS of $0.11, for the Quarter
- Strong Sales of Key Pharmaceutical Products; Solid Performance by Consumer Care and Animal Health Units
- New Product Launches and Progressing Pipeline Drive Business Momentum
- On Track to Meet Synergy Target of $3.5 Billion in Annual Savings by End of 2012
- Raised Lower End of 2010 Non-GAAP EPS Target Range Due to Solid Year-to-Date Performance; Long-Term Non-GAAP EPS Growth Rate Target Reaffirmed
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Oct 29, 2010 - Merck & Co., Inc. (NYSE: MRK) today announced financial results for the third quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the third quarter of $0.85, which excludes purchase accounting adjustments, restructuring costs, merger-related expenses and a $950 million legal reserve. Third-quarter GAAP EPS was $0.11.
Worldwide sales for the third quarter of 2010 were $11.1 billion. Net income1 for the third quarter was $342 million.
For the first nine months of 2010, worldwide sales were $33.9 billion and net income was $1.4 billion.
A reconciliation of EPS as reported in accordance with GAAP to EPS, excluding certain items, is provided in the table that follows. The third quarter and year-to-date 2009 results below reflect legacy Merck on a stand-alone basis.
Quarter Ended Sept. 30 | Nine Months Ended Sept. 30 | |||||||
2010 | 2009 | 2010 | 2009 | |||||
$ 0.11 | $ 1.61 | $ 0.44 | $ 3.03 | ||||
EPS impact
of items*
0.74 | (0.71) | 2.10 | (0.56) | ||||
Non-GAAP EPS that excludes certain items listed
$ 0.85
$ 0.90
$ 2.54
$ 2.47
Amount calculated as follows (in millions except per share
Quarter 2010 |
Quarter 2009 |
Ended Sept. 30, 2010 |
Ended Sept. 30, 2009 |
Purchase accounting adjustments | $ 1,540 | $ -- | $ 5,576 | $ -- | ||||
Merger restructuring program | 384 | -- | 1,497 | -- | ||||
Costs related to other restructuring programs | 3 | 117 | 135 | 484 | ||||
Merger-related costs | 64 | 144 | 235 | 257 | ||||
Legal reserve | 950 | -- | 950 | -- | ||||
Gain on AstraZeneca's asset option exercise | -- | -- | (443) | -- | ||||
Gain from sale of interest in Merial | -- | (2,763) | -- | (2,763) | ||||
Net decrease (increase) in income before taxes | 2,941 | (2,502) | 7,950 | (2,022) | ||||
Income tax
(benefit) expense3
(638) | 986 | (1,383) | 848 | ||||
Decrease (increase) in net income | $ 2,303 | $ (1,516) | $ 6,567 | $ (1,174) | ||||
EPS impact of items | $ 0.74 | $ (0.71) | $ 2.10 | $ (0.56) |
Select Business Highlights
- New four-year data on odanacatib, the company's investigational treatment for osteoporosis in post-menopausal women, was presented last week at the American Society for Bone and Mineral Research annual meeting. Clinical and preclinical studies continue to provide data on the potential of odanacatib to increase bone density, cortical thickness and bone strength when treating osteoporosis.
- Also, full data results for two pivotal late-stage studies for boceprevir, for the treatment of hepatitis C, will be presented Nov. 1 and 2 at the annual meeting of the American Association for the Study of Liver Disease.
- Safety and efficacy data from the DEFINE study for anacetrapib for the treatment of atherosclerosis will be presented in a late-breaker presentation on Nov. 17, at the American Heart Association's Scientific Sessions.
- In the quarter, the company also launched three new medicines: the intravenous (IV) formulation of BRINAVESS (vernakalant) for the treatment of atrial fibrillation in adults in the European Union (EU), Iceland and Norway; DULERA (mometasone furoate and formoterol fumarate dihydrate) for the treatment of asthma in the United States; and DAXAS (roflumilast) for the treatment of symptomatic COPD in Canada and certain European markets, through a partnership.
- The company is making progress growing its business in emerging markets, with 18 percent of sales from human health pharmaceuticals and vaccines coming from these markets in the quarter.
- Merck continues to secure strategic research and development collaborations, including agreements this quarter with Alectos Therapeutics and NicOx, to develop targeting technologies for new compounds. In addition, the company signed an agreement to allow Lundbeck to distribute SYCREST (asenapine), Merck's treatment for bipolar disorder, in all markets outside the United States, China and Japan.
- Merck's subsidiary, Schering-Plough (Ireland) Company and Centocor Ortho Biotech Inc., a Johnson & Johnson subsidiary, have concluded the arbitration hearing regarding Remicade and Simponi, and will file post-hearing briefs and present arguments to the arbitration panel in late December. Merck anticipates a decision in 2011.
Third-Quarter Financial Results
The following supplemental combined third-quarter 2009 non-GAAP sales are adjusted to reflect a full quarter of legacy Merck and legacy Schering-Plough combined results. This supplemental information is provided to enhance investors' understanding of the company's products and overall business performance and should be considered in addition to, but not in lieu of, sales recorded in accordance with GAAP.
Adj. 3Q09 |
Non-GAAP 3Q09 |
$ 11,125 | $ 6,050 | $ 5,481 | $ 11,531 | ||||
9,660 | 5,676 | 4,425 | 10,101 | ||||
687 | --- | 664 | 664 | ||||
291 | --- | 283 | 283 | ||||
487 | 374 | 109 | 483 |
Materials and production costs were $4.2 billion for the third quarter of 2010, compared to $1.4 billion for the third quarter of 2009. The third quarter of 2010 includes $1.4 billion of costs related to the amortization of intangible assets and purchase accounting adjustments to inventories as a result of the merger. The third quarters of 2010 and 2009 include $44 million and $27 million, respectively, for costs associated with restructuring programs. The gross margin was 62.3 percent for the third quarter of 2010, reflecting a 12.6 percentage point unfavorable impact from the purchase accounting adjustments and restructuring costs noted above.
Marketing and administrative expenses were $3.2 billion for the third quarter of 2010, which include $130 million of restructuring costs and $64 million of merger-related costs. Marketing and administrative costs were $1.7 billion for the third quarter of 2009. Costs for the third quarter of 2009 include $56 million of merger-related expenses.
Research and development expenses were $2.3 billion for the third quarter of 2010, which include $189 million for in-process research and development impairments and $163 million for restructuring activities. Expenses for 2009 were $1.3 billion for the quarter, which include $48 million of costs for restructuring activities.
Restructuring costs, primarily related to employee separations, were $50 million for the third quarter of 2010 compared with $42 million for the third quarter of 2009.
Total overall costs associated with the company's global restructuring programs included in materials and production, marketing and administrative, research and development, and restructuring costs were $387 million and $117 million for the third quarters of 2010 and 2009, respectively, primarily comprised of employee separation costs and accelerated depreciation.
Equity income from affiliates was $236 million in the third quarter of 2010. Equity income from affiliates no longer reflects any contribution from the Merck/Schering-Plough partnership or from Merial Limited.
Other (income) expense was $1.1 billion of expense in the third quarter of 2010, which includes the unfavorable impact of a $950 million legal reserve, compared with $2.8 billion of income in the third quarter of 2009, which included the gain on the sale of Merck's interest in Merial Limited. The company has established the legal reserve in connection with an anticipated resolution of the previously disclosed investigation by the U.S. Attorney's Office for the District of Massachusetts related to VIOXX. Merck's discussions with the government are ongoing. Until they are concluded, there can be no certainty about a definitive resolution.
The GAAP effective tax rate of 25.3 percent for the third quarter of 2010 reflects the impact of the legal reserve referred to above, restructuring costs and purchase accounting adjustments. It also includes a $380 million tax benefit from changes in a foreign entity's tax rate that became effective in the third quarter, resulting in a reduction in deferred tax liabilities on product intangibles recorded in conjunction with the merger. The non-GAAP effective tax rate, which excludes all these items, was 22.2 percent for the quarter.
Financial Targets
For 2010, Merck raised the lower end of the non-GAAP EPS range and is now targeting a range of $3.31 to $3.39, excluding certain items, and a 2010 GAAP EPS range of $0.66 to $0.97. The 2010 non-GAAP range excludes purchase accounting adjustments, restructuring and merger-related costs, the first-quarter tax charge related to U.S. health care reform legislation, the second-quarter gain on AstraZeneca's asset option exercise, and the third-quarter $950 million legal reserve. EPS and other financial targets for 2010 assume that Merck will retain full rights to REMICADE and SIMPONI in the applicable markets.
A reconciliation of anticipated 2010 EPS as reported in accordance with GAAP to non-GAAP EPS that excludes certain items is provided in the table that follows:
Full-Year 2010 | |||
to $0.97
EPS impact
of items*
$2.65 to
Non-GAAP EPS that excludes certain items listed below | $3.31
to $3.39
* Amount calculated as follows (in millions except per share amounts) | Full-Year 2010 | |
Purchase accounting adjustments | $7,000 to $6,500 | |
Costs related to restructuring programs | 2,000 to 1,700 | |
Merger-related costs | 350 to 250 | |
Legal reserve | 950 | |
Gain on AstraZeneca's asset option exercise | (443) | |
Net decrease (increase) in income before taxes | 9,857 to 8,957 | |
Income tax
(benefit) expense6
(1,593) to (1,423) | |
Decrease (increase) in net income | $8,264 to $7,534 | |
EPS impact of items | $2.65 to $2.42 |
Non-GAAP research and development expense, which excludes joint ventures, is anticipated to be approximately $8.2 billion to $8.6 billion for the full year of 2010. This target excludes the portion of the restructuring costs and any in-process R&D impairment charges included in research and development expense for 2010.
Merck continues to estimate that its consolidated non-GAAP 2010 tax rate will be approximately 22 percent to 24 percent.
Merck continues to target a high single-digit non-GAAP EPS compound annual growth rate for the combined company from 2009 to 2013 when compared to Merck's 2009 non-GAAP EPS. As the company has previously said, the longer-term target is applicable regardless of the assumptions made for the REMICADE and SIMPONI business.
Product Performance – Human Health
The sales figures discussed below for legacy Schering-Plough products are reported on a GAAP basis, which represents sales for the third quarter of 2010 only.
Bone, Respiratory, Immunology and Dermatology
Worldwide sales of SINGULAIR (montelukast sodium), a once-a-day oral medicine indicated for the chronic treatment of asthma and the relief of symptoms of allergic rhinitis, were $1.2 billion for the third quarter of 2010, an increase of 12 percent compared with the third quarter of 2009.
Global sales of NASONEX (mometasone furoate monohydrate), nasal spray, an inhaled nasal corticosteroid for the treatment of nasal allergy symptoms, were $259 million for the third quarter of 2010.
Sales of REMICADE (infliximab) were $661 million for the third quarter of 2010. REMICADE is a treatment for inflammatory diseases which is marketed by Merck in countries outside the United States (except in Japan and certain other Asian markets). In addition, SIMPONI (golimumab), a once-monthly, subcutaneous treatment for certain inflammatory diseases, has been launched in 18 countries, and launches in other international markets are planned.
Global sales of ZETIA (ezetimibe) and VYTORIN (ezetimibe/simvastatin) were $571 million and $485 million, respectively, for the third quarter of 2010. Combined global sales of ZETIA and VYTORIN were $1.1 billion for the third quarter of 2010.
Diabetes and Obesity
JANUVIA (sitagliptin), Merck's DPP-4 inhibitor for the treatment of type 2 diabetes, recorded worldwide sales of $600 million during the third quarter of 2010, representing a 22 percent increase compared with the same quarter in 2009. JANUMET (sitagliptin/metformin hydrochloride), a single tablet that targets all three key defects of type 2 diabetes, achieved worldwide sales of $247 million during the quarter, an increase of 43 percent compared with the third quarter 2009. The JANUVIA/JANUMET combined franchise had sales of $847 million during the third quarter of 2010, an increase of 28 percent compared to the same quarter in 2009.
Infectious Disease
ISENTRESS (raltegravir), an HIV integrase inhibitor for use in combination with other antiretroviral agents for the treatment of HIV-1 infection, reported worldwide sales of $278 million for the third quarter of 2010, an increase of 41 percent compared with the third quarter of 2009.
Worldwide sales of PEGINTRON (peginterferon alfa-2b) for chronic hepatitis C were $168 million for the third quarter of 2010.
Diversified Brands
Merck's diversified brands are human health pharmaceutical products that are approaching the expiration of their marketing exclusivity or are no longer protected by patents in developed markets, but continue to be a core part of the company's offering in other markets around the world.
Global sales of Merck's antihypertensive medicines, COZAAR (losartan potassium) and HYZAAR7 (losartan potassium and hydrochlorothiazide), were $423 million for the third quarter of 2010, representing a 51 percent decrease compared with the third quarter of 2009. The company continues to experience a decline in COZAAR/HYZAAR sales since these medicines have lost marketing exclusivity in the United States and in major European markets.
Neuroscience and Ophthalmology
Global sales of MAXALT (rizatriptan benzoate), Merck's tablet for the treatment of acute migraine, were $133 million for the third quarter of 2010, an 8 percent decrease from the same quarter last year.
Sales of TEMODAR (temozolomide), a treatment for certain types of brain tumors, were $254 million for the third quarter of 2010.
Sales of CAELYX (pegylated liposomal doxorubicin hydrochloride) for the treatment of ovarian cancer, metastatic breast cancer and Kaposi's sarcoma, were $70 million for the third quarter of 2010. As previously disclosed, marketing rights for CAELYX will transition to Johnson & Johnson as of Dec. 31, 2010.
Total sales as recorded by Merck of its cervical cancer vaccine, GARDASIL (human papillomavirus (HPV) quadrivalent (types 6, 11, 16, 18) vaccine, recombinant), were $316 million for the third quarter of 2010, a 2 percent increase from the same quarter in 2009. Sales, in part, benefited from the timing of certain public sector sales.
Worldwide sales of Merck's other viral vaccines, which include VARIVAX (varicella virus vaccine live), M-M-R II (measles, mumps and rubella virus vaccine live) and PROQUAD (measles, mumps, rubella and varicella virus vaccine live), as recorded by Merck, were $434 million for the third quarter of 2010, a decrease of 6 percent compared with the same period a year earlier.
ZOSTAVAX (zoster vaccine live), the company's vaccine to help prevent shingles (herpes zoster), recorded sales of $23 million for the third quarter of 2010 compared with $84 million for the third quarter of 2009. Sales during the quarter were limited by continuing supply constraints.
Women's Health and Endocrine
Global sales of NUVARING (etonogestrel/ethinyl estradiol vaginal ring), a contraceptive product, were $134 million for the third quarter of 2010.
Sales of FOLLISTIM/PUREGON (follitropin beta injection), a fertility treatment, were $119 million for the third quarter of 2010.
Product Performance • Animal Health
Animal Health sales totaled $687 million for the third quarter of 2010, reflecting continued solid performance among poultry, swine and aquatic products. Animal Health includes pharmaceutical and vaccine products for the prevention, treatment and control of disease in all major farm and companion animal species. Merck's Animal Health business is subject to a proposed joint venture with sanofi-aventis which the company expects to close in the first quarter of 2011.
Product Performance • Consumer Care
Consumer Care sales were $291 million for the third quarter of 2010, which reflect continued strong performance of a number of key brands including DR. SCHOLL's, CLARITIN and COPPERTONE. Consumer Care includes footcare and suncare consumer products, and a variety of over-the-counter medicines.
Total Employees
As of Sept. 30, Merck had approximately 93,000 employees worldwide.
Explanatory Note
Supplemental combined non-GAAP sales are provided in the attached schedules at the end of this news release to reflect the revenues of the company's product sales on a comparable basis to periods prior to the merger. Merck has defined supplemental combined non-GAAP sales as GAAP sales adjusted to reflect a full quarter of Merck and Schering-Plough performance as if the merger closed at the beginning of the periods indicated in the applicable table. This supplemental information is provided to enhance investors' understanding of the company's products and overall business performance. This information should be considered in addition to, but not in lieu of, sales recorded in accordance with GAAP. Supplemental combined non-GAAP sales are available in Tables 3 and 3a as part of this news release, and additional information is included in the 8-K filing today.
Earnings Conference Call
Investors are invited to a live audio webcast of Merck's third-quarter earnings conference call today at 8:00 a.m. EDT by visiting Merck's Web site, www.merck.com/investors/events-and-presentations/home.html. Institutional investors and analysts can participate in the call by dialing (706) 758-9927 or (877) 381-5782. Journalists are invited to listen in on the call by dialing (706) 758-9928 or (800) 399-7917. A replay of the webcast will be available starting at 11 a.m. EDT today through 5 p.m. EDT on Nov. 6. To listen to the replay, dial (706) 645-9291 or (800) 642-1687 and enter ID No. 11269659.
About Merck
Today's Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships that donate and deliver our products to the people who need them. For more information, visit www.merck.com.
Forward-Looking Statement
This news release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such statements may include, but are not limited to, statements about the benefits of the merger between Merck and Schering-Plough, including future financial and operating results, the combined company's plans, objectives, expectations and intentions and other statements that are not historical facts. Such statements are based upon the current beliefs and expectations of Merck's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements.
The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: the possibility that the expected synergies from the merger of Merck and Schering-Plough will not be realized, or will not be realized within the expected time period; the impact of pharmaceutical industry regulation and health care legislation; the risk that the businesses will not be integrated successfully; disruption from the merger making it more difficult to maintain business and operational relationships; Merck's ability to accurately predict future market conditions; dependence on the effectiveness of Merck's patents and other protections for innovative products; the risk of new and changing regulation and health policies in the U.S. and internationally and the exposure to litigation and/or regulatory actions.
Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in Merck's 2009 Annual Report on Form 10-K and the company's other filings with the Securities and Exchange Commission (SEC) available at the SEC's Internet site (www.sec.gov).
1 Net income attributable to Merck & Co., Inc.
2 Merck is providing information on 2010 and 2009 non-GAAP earnings per share that excludes certain items because of the nature of these items and the impact they have on the analysis of underlying business performance and trends. Management believes that providing this information enhances investors' understanding of the company's performance. This information should be considered in addition to, but not in lieu of, earnings per share prepared in accordance with GAAP. For a description of the items, see Tables 2a and 2b, including the related footnotes, attached to this release.
3 Includes an estimated income tax (benefit) expense on the reconciling items. In addition, amounts for the three and nine months ended September 30, 2010 include a $380 million tax benefit from changes in a foreign entity's tax rate, which resulted in a reduction in deferred tax liabilities on product intangibles recorded in conjunction with the merger. The amount for the nine months ended September 30, 2010 also reflects a $147 million tax charge related to U.S. health care reform legislation.
4 Human Health includes worldwide prescription pharmaceutical sales and consumer product sales excluding the U.S. and Canada. Consumer Care includes U.S. and Canada consumer product sales.
5 Other revenues are primarily comprised of alliance revenue, miscellaneous corporate revenues and third party manufacturing sales. Revenue from AstraZeneca LP recorded by Merck was $345 million in the third quarter of 2010.
6 Represents an estimated income tax (benefit) expense on the reconciling items, as well as a $380 million tax benefit from changes in foreign entity's tax rate and a $147 million tax charge related to U.S. health care reform.
7 COZAAR and HYZAAR are registered trademarks of E.I. duPont de Nemours and Company, Wilmington, Del.
8 Vaccines in most major European markets are sold through the company's joint venture, Sanofi Pasteur MSD, and the results from the company's interest in the joint venture are recorded in equity income from affiliates.
% Change
% Change
Sales | $ 11,124.9 | $ 6,049.7 | 84% | $ 33,893.3 | $ 17,334.8 | 96% | ||||||
Costs, Expenses and Other | ||||||||||||
Materials and production (1) | 4,191.4 | 1,430.3 | * | 13,955.9 | 4,118.0 | * | ||||||
Marketing and administrative (2) | 3,217.9 | 1,725.5 | 86% | 9,666.8 | 5,088.0 | 90% | ||||||
Research and development (3) | 2,296.4 | 1,254.0 | 83% | 6,474.0 | 3,873.5 | 67% | ||||||
Restructuring costs (4) | 49.6 | 42.4 | 17% | 863.6 | 144.1 | * | ||||||
Equity income from affiliates (5) | (236.4) | (688.2) | -66% | (416.8) | (1,861.2) | -78% | ||||||
Other (income) expense, net (6) | 1,108.3 | (2,791.1) | * | 995.6 | (2,854.7) | * | ||||||
Income Before Taxes | 497.7 | 5,076.8 | -90% | 2,354.2 | 8,827.1 | -73% | ||||||
Taxes on Income | 126.0 | 1,621.5 | 872.2 | 2,327.7 | ||||||||
Net Income | 371.7 | 3,455.3 | -89% | 1,482.0 | 6,499.4 | -77% | ||||||
Less: Net Income Attributable to Noncontrolling Interests | 30.1 | 31.0 | 89.3 | 93.8 | ||||||||
Net Income Attributable to Merck & Co., Inc. | $ 341.6 | $ 3,424.3 | -90% | $ 1,392.7 | $ 6,405.6 | -78% | ||||||
Earnings per Common Share Assuming Dilution (7) | $ 0.11 | $ 1.61 | -93% | $ 0.44 | $ 3.03 | -85% | ||||||
Average Shares Outstanding Assuming Dilution | 3,101.6 | 2,113.7 | 3,123.3 | 2,110.6 | ||||||||
Tax Rate (8) |
Posted: October 2010
Recommended for you


text:
In the brain, transient and lasting changes in the efficacy of synaptic transmission continually shape neuronal circuits to process information. These changes, at least in part, are caused by endocannabinoid (EC) signaling, which has been broadly recognized to control neurotransmitter release at transient (high-intensity phasic) and lasting (low-intensity tonic) time scales, and to additionally mediate long-term synaptic plasticit in multiple brain regions. Although the clinical targeting of the cannabinoid type-1 receptors carries significant therapeutic potential, the neurobiological consequences of EC signaling at distinct timescales are not understood. A major reason for this gap in our knowledge is that at present, no manipulation is available which selectively interferes with phasic or tonic EC signaling. This study aims to fill this gap by following up on our preliminary findings that sugges an unexpected role for neuroligins in EC signaling. Specifically, we have found that neuroligin-3 is essential for tonic but not phasic EC signaling. Neuroligins are postsynaptic cell-adhesion molecules that control diverse, yet synapse-specific, features in central synapses. To examine how the loss of neuroligins affect EC signaling, we will first focus on well-characterized EC-sensitive hippocampal synapses, and second, extend these studies to the circuitry of the ventral tegmental area (VTA), which is known to relay multiple EC-sensitive inputs to shape diverse motivation- and addiction-related behaviors. A better understanding of the molecular specificity underlying EC signaling in distinct timescales and brain regions will enable us to examine their mechanisms and biological significance. Furthermore, by employing a combination of paired-recording electrophysiology and molecular biology, this study will offer novel insights to the loca circuitry of the VTA, which may help to establish a causal relationship between the structure of VTA and the ability of drugs of abuse to elicit prolonged or even irreversible changes within it.
Endocannabinoids (EC) are key regulators of brain function that modulate synaptic transmission in phasic (high-intensity, acute) and tonic (low-intensity, chronic) modes by activating the same receptors;however, the mechanisms and biological significance of the two modes of EC signaling are not understood, and current treatments indiscriminately target both modes. Based on our recent discovery of a selective role for neuroligin-3 in controlling tonic EC signaling, we here propose experiments that will clarify the nature of the two EC signaling modes and facilitate better targeting of these modes in neuropsychiatric diseases.
Foldy, Csaba; Malenka, Robert C; Sudhof, Thomas C (2013) Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling. Neuron 78:498-509 |


text:
Kirsten Dunst: Tallarico Designs Shopping Trip!
Kirsten Dunst leaves Tallarico Designs jewelry store on Wednesday (November 10) in Los Angeles.
The 28-year-old actress, who sported a new, shorter hairdo, left the store with a small bag.
Kirsten's next film, All Good Things, will hit movie theaters on December 3! She stars opposite Ryan Gosling in the love story and murder mystery.
Check out the trailer for All Good Things here if you haven't seen it yet!